LPL Financial
ALGS icon

LPL Financial’s Aligos Therapeutics ALGS Stock Holding History

LPL Financial’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$383K Sell
51,500
-14,500
-22% -$110K ﹤0.01% 5007
2025
Q4 		$615K Buy
66,000
+10,880
+20% +$103K ﹤0.01% 4537
2025
Q3 		$540K Buy
55,120
+25,020
+83% +$229K ﹤0.01% 4556
2025
Q2 		$217K Buy
+30,100
New +$180K ﹤0.01% 5029

Other funds holding ALGS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

LPL Financial's ALGS Position: Q1 2026 in Review

LPL Financial reduced its Aligos Therapeutics (ALGS) stake by 22% in Q1 2026, selling an estimated $110K and leaving 51,500 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #5007.

LPL Financial first reported a position in ALGS in Q2 2025 and has held it in 4 quarters since. The position peaked at $615K in Q4 2025. 35 funds tracked by Wall St. Rank hold ALGS as of Q1 2026.

  • LPL Financial held 51,500 shares of Aligos Therapeutics worth $383K as of Q1 2026.
  • LPL Financial sold 14,500 Aligos Therapeutics shares in Q1 2026, an estimated $110K.
  • Aligos Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5007 holding.
  • LPL Financial first reported a position in Aligos Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • LPL Financial's Aligos Therapeutics position peaked at $615K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.